Vince Burgess

  • Executive Chairman, Venture Partner, OrbiMed.

Vince Burgess is a Venture Partner with OrbiMed. Mr. Burgess has over 20 years of experience in healthcare operations, business development and venture capital. Vince was on the founding executive team at Volcano, where he was President, Advanced Imaging Systems, and also led marketing and business development from 2002 to 2010. At Volcano, he was a key architect of the company’s product, marketing and M&A strategies. During his tenure, Volcano grew from a start-up to a global company with over 1,000 employees and a market cap of over $1.2 billion. Mr. Burgess previously served as a partner of Sorrento Ventures and has operational and board experience in the surgical tool, ophthalmology and healthcare I.T. fields. Mr. Burgess earned his M.B.A. at UCLA and his B.S. in Business Administration from USC.

Nissim Darvish, MD, Ph.D.

  • Senior Managing Director, OrbiMed

Dr. Darvish is a Senior Managing Director at OrbiMed. He is a veteran of the life-science industry, with fifteen years of experience covering medical technology development, corporate leadership and investment management. Dr. Darvish spent eight years with Pitango, where he was a General Partner managing life science investments. Previously, he was the founder and CEO of Impulse Dynamics, which he led for six years, culminating in a $250 million realization event. Dr. Darvish obtained his M.D. and Ph.D. in Biophysics and Physiology from the Technion in Israel, and subsequently conducted his postdoctoral research at the NIH. He has published over one hundred patents, authored over twenty publications and received eight prizes and awards. Dr. Darvish has served on boards of multiple companies, including Inotek Pharmaceuticals Inc., SuperDimension, Vascular Biogenics and Inca Medical.

David Ataide

David Ataide is a private business consultant and 30 year veteran of the healthcare industry. Most recently David held senior level executive positions at GE Healthcare, where he served as VP Strategic Initiatives, Operating Partner for GE Ventures and Vice President & General Manager of the Patient Monitoring and Diagnostic Cardiology businesses. David came to GE from Philips Medical Systems, where he was Chief Marketing Officer, with overall responsibility for marketing at Philips’ $6.2B healthcare division. David’s past assignments include successful leadership roles in sales, marketing and general management at Philips, Agilent Technologies and Hewlett-Packard’s Medical Products Group. In addition, he has domain expertise in a wide variety of medical capital equipment, imaging and IT markets. David holds a Master of Science degree in Nursing Administration and Critical Care from the University of California at San Francisco, San Francisco, California, and a Bachelor of Science Degree in Nursing from San Jose State University, San Jose, California.

Peggie Wang

  • Founder & Managing Director of LongTec HongTao China Ventures LP
  • Managing Director of Shanghai Liontown Medical Device Co., Ltd.

Founder & Managing Director of LongTec China Ventures LP; Chairman & CEO of Shanghai LongTec Medical Technology Co., Ltd.; engaged in healthcare industry for 15 years, international and domestic market access (registration and certification of products) of medical devices for 10 years and overseas investment of medical devices for 5 years.
After her 5 years of employment by TUV SUD GROUP, she became General Manager of MEDCERT Greater China , GL Group, and developed MEDCERT to become the third largest certification organization for medical devices in China within 3 years. As an expert for medical device regulatory, she worked intensively with 1500 medical device companies for Regulatory affairs, including big multinationals.
She co-founded LongTec China Ventures LP, and thus is the first Chinese VC fund investing in Israeli MEDTECH innovation companies. Since 5 years, She and her partners have brought LongTec as one of the most famous and professional cross-border VC funds in MEDTECH from China in the US and Israel.

Robert A. Schindler, MD

Professor Emeritus and former Chairman of the Department of Otolaryngology-Head and Neck Surgery at UCSF. Graduated summa cum laude in Medical Sciences from UCSF where he completed residency and post-doctoral work in auditory neuroscience. Professor Schindler is the founding director of the S&I Epstein Otoneurological Laboratory where he established the first electron microscopic laboratory at UCSF devoted to hearing research. His awards include an NIH Fogarty Fellowship, the Edmond Prince Fowler Award, and Dr. Schindler was noted by Science Digest (Dec. 1985) as one of America’s “Outstanding Innovators” for his co-invention of the multichannel cochlear implant. He Dr. Schindler led the clinical team that developed the Clarion implant which is now one of most widely used Cochlear Implants in the world. More recently, he Dr. Schindler co-invented and led the clinical development of the Lyric hearing aid, the first continuously worn, totally in the canal hearing aid. He Dr. Schindler holds a number of patents, and has served on the Boards of several medical device companies. Dr. Schindler graduated from UCSF, in Medical Sciences (summa cum laude).

Noah Lewis

  • Managing Director, GE Ventures

Noah is a Managing Director at GE Ventures, specializing in MedTech and SaaS investing-with a focus on disease management business models integrating smart devices, software analytics and services. He founded GE Ventures portfolio operating practice and dedicates much of his time growing his previous investments including board positions at Ornim Medical, Veran Medical and Acutus Medical. Prior to entering venture capital, Noah led strategic planning for the $10B GE Healthcare Systems division and started his career in the technology industry at IBM. Noah holds an M.B.A. degree from MIT and a B.S. degree from Skidmore College.